Brief: Lyra Therapeutics Inc Withdraws Appeal Of Nasdaq Delisting Determination - SEC Filing
March 16 (Reuters) - Lyra Therapeutics Inc LYRA.O: LYRA THERAPEUTICS INC - WITHDRAWS APPEAL OF NASDAQ DELISTING DETERMINATION - SEC FILING LYRA THERAPEUTICS INC - TRADING IN LYRA THERAPEUTICS STOCK TO BE SUSPENDED AT OPEN ON MARCH 17, 2026 - SEC FILING Further company coverage: LYRA.O ((Reuters.Briefs@thomsonreuters.com;))